CoChat

Proton pump inhibitor use and hearing loss in patients with type 2 diabetes: Evidence from a hospital‐based case‐control study and a population‐based cohort study

Yee, Jeong, Han, Hye Won, Gwak, Hye Sun · 2022 · British Journal of Clinical Pharmacology

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

Objectives: This study aimed to investigate the association between proton pump inhibitor (PPI) use and risk of sensorineural hearing loss (SNHL) or tinnitus in patients with type 2 diabetes using hospital‐ and population‐based data. Methods: For the case‐control study using the Asan Biomedical Research Environment database, the characteristics between cases and sex‐, age‐ and index‐year‐matched controls were compared by the chi‐squared test. Conditional logistic regression was used to estimate the odds ratios (ORs). For the cohort study using the Korean National Health Insurance Service – National Sample Cohort, the hazard ratios (HRs) for SNHL or tinnitus associated with PPI use were analysed by the Cox proportional hazard regression model. Results: The case‐control study included 1379 cases and 5512 matched controls. After adjustment, PPI use was associated with an increased risk of SNHL or tinnitus (OR 1.61, 95% confidence interval [CI] 1.30‐1.99). The ORs were higher for current or recent use of PPI and high average daily dose. In the cohort study including 17 233 pairs of PPI users and nonusers after propensity score matching, the risk of SNHL or tinnitus increased in PPI users compared with nonusers (HR 1.50, 95% CI 1.40‐1.61). In the stratified analyses, risks remained significant and the magnitude of association was relatively high in those of younger age, patients without gastroesophageal reflux disease and patients not receiving histamine 2 receptor blockers. Conclusions: Our study suggests that PPI use is associated with an increased risk of SNHL or tinnitus. Given the widespread use of PPIs, the potential ototoxic effects of PPIs remain an important concern.

Overview

Integrity signals

Registry

Crossref · 10.1111/bcp.15210

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 44 references

Research works printed but not linked: 3

  1. World Health Organization, 2021, Deafness and hearing loss factsheet
  2. WHO Collaborating Centre for Drug Statistics Methodology, 2018, Defined daily doses
  3. UpToDate, 2021, Main causes of sudden sensorineural hearing loss

Cited by

Metadata

Authors
Yee, J., Han, H. W., & Gwak, H. S.
Affiliations
Ewha Womans University (KR)
Corresponding author
Gwak, Hye Sun
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
2022-01-13
Volume
88
Issue
6
Pages
2738-2746
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W4205497638
Cited by
11
References
44
Citations by year
2025: 6 · 2024: 2 · 2023: 2 · 2022: 1
FWCI
1.44
Type
journal article
Language
en
Open access
closed
Locations
  • British Journal of Clinical Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
  • Health Sciences › Health Professions › Speech and Hearing › Hearing Loss and Rehabilitation
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
proton pump inhibitors, sensorineural hearing loss, tinnitus, type 2 diabetes, ototoxicity, drug safety, H2 receptor antagonists, gastroesophageal reflux disease, dose-response relationship
MeSH terms
Diabetes Mellitus, Type 2, Hospitals, Humans, Risk Factors, Tinnitus, Cohort Studies, Case-Control Studies, Hearing Loss, Proton Pump Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.